Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis-Reference-Cited by-同舟云学术

Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis

Published:2022-02-01 Issue:2 Volume:15 Page:167-173
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Shah Nirmish¹,Lipato Thokozeni²,Alvarez Ofelia³,Delea Thomas⁴,Lonshteyn Alexander⁴^ORCID,Weycker Derek⁴^ORCID,Nguyen Andy⁵,Beaubrun Anne⁵,Agodoa Irene⁵

Affiliation:

1. Division of Hematology, Division of Pediatric Hematology/Oncology, Duke University School of Medicine, Durham, North Carolina, USA

2. Department of Internal Medicine, VCU Health, Richmond, Virginia, USA

3. Division of Pediatric Hematology/Oncology, University of Miami, Miami, Florida, USA

4. Policy Analysis Inc. (PAI), Brookline, Massachusetts, USA

5. Global Blood Therapeutics, South San Francisco, California, USA

Funder

Global Blood Therapeutics

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2022.2031967

Reference26 articles.

1. Centers for Disease Control and Prevention [Internet]. Data and statistics on sickle cell disease cited 2021 Aug 18. Available from: https://www.cdc.gov/ncbddd/sicklecell/data.html

2. Sickle cell disease

3. Sickle cell disease

4. Sickle Cell Disease

5. Mortality Rates and Age at Death from Sickle Cell Disease: U.S., 1979–2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Newer Modalities and Updates in the Management of Sickle Cell Disease: A Systematic Review;Journal of Blood Medicine;2024-09

2. Standardization of coding definitions for sickle cell disease complications: A systematic literature review;Pharmacoepidemiology and Drug Safety;2024-08-28

3. Modulation of the allosteric and vasoregulatory arms of erythrocytic oxygen transport;Frontiers in Physiology;2024-06-10

4. Disease-Modifying Therapies for Sickle Cell Disease—An Overview;Pediatric Annals;2024-02

5. Management of Acute Sickle Cell Disease Pain;Pediatrics in Review;2024-01-01